Literature DB >> 24121986

Bisphosphonate-associated fractures of the femur: pathophysiology and treatment.

Thomas A Einhorn1, Yelena Bogdan, Paul Tornetta.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2014        PMID： 24121986     DOI： 10.1097/BOT.0000000000000023

Source DB:  PubMed          Journal:  J Orthop Trauma        ISSN： 0890-5339            Impact factor:   2.512


× No keyword cloud information.
  8 in total

1.  Atypical femur fracture during bisphosphonate drug holiday: a case series.

Authors:  A J Lovy; S M Koehler; A Keswani; D Joseph; R Hasija; R Ghillani
Journal:  Osteoporos Int       Date:  2015-04-02       Impact factor: 4.507

2.  A review of atypical subtrochanteric femoral fractures in Northern Ireland between 2010 and 2014.

Authors:  K J Donnelly; A Tucker; B Kerr; S McDonald; D S O'Longain; J D Acton
Journal:  Eur J Orthop Surg Traumatol       Date:  2017-12-22

3.  Atraumatic segmental atypical femur fracture secondary to bisphosphonate use: A case report.

Authors:  Andrew J Lovy; Diana Patterson; Laura Skeeles; Richard Ghillani; David Joseph; Yangguan Wu; Rohit Hasija
Journal:  J Clin Orthop Trauma       Date:  2017-03-19

4.  Long-term radiographic follow-up of bisphosphonate-associated atypical femur fractures.

Authors:  Jennifer L Favinger; Daniel Hippe; Alice S Ha
Journal:  Skeletal Radiol       Date:  2016-02-15       Impact factor: 2.199

5.  Deciphering the underlying mechanism of Xianlinggubao capsule against osteoporosis by network pharmacology.

Authors:  Hangsheng Bao; Huizhi Guo; Zongquan Feng; Xin Li
Journal:  BMC Complement Med Ther       Date:  2020-07-03

6.  Atypical periprosthetic femur fracture on an underestimated atypical femoral pattern. A case report.

Authors:  Gaetano Caruso; Nicola Corradi; Tommaso Amoroso; Ilaria Martini; Vincenzo Lorusso; Leo Massari
Journal:  Trauma Case Rep       Date:  2021-02-10

7.  Deciphering the molecular mechanism underlying the effects of epimedium on osteoporosis through system bioinformatic approach.

Authors:  Keliang Wu; Linjing Han; Ying Zhao; Qinghua Xiao; Zhen Zhang; Xiaosheng Lin
Journal:  Medicine (Baltimore)       Date:  2022-08-12       Impact factor: 1.817

8.  Polydatin improves osteogenic differentiation of human bone mesenchymal stem cells by stimulating TAZ expression via BMP2-Wnt/β-catenin signaling pathway.

Authors:  Ying-Shan Shen; Xiao-Jun Chen; Sha-Na Wuri; Fan Yang; Feng-Xiang Pang; Liang-Liang Xu; Wei He; Qiu-Shi Wei
Journal:  Stem Cell Res Ther       Date:  2020-05-27       Impact factor: 6.832
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.